<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39361181</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1437-7799</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Oct</Month><Day>03</Day></PubDate></JournalIssue><Title>Clinical and experimental nephrology</Title><ISOAbbreviation>Clin Exp Nephrol</ISOAbbreviation></Journal><ArticleTitle>Outcomes of kidney transplantation in recipients with SARS-cov-2 infection: a 282-case single-center experience in Japan.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10157-024-02560-0</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The coronavirus disease 2019, caused by severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2), has become a global epidemic. There are concerns regarding the severity of SARS-CoV-2 infections in kidney transplant (KTx) recipients. However, there is limited data on how the epidemic has affected the treatment and prognosis of these patients. Therefore, we aimed to report the changes in the treatment and outcomes of KTx recipients infected with SARS-CoV-2 during each wave at our institution.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A total of 282 KTx recipients who were infected with SARS-CoV-2 during the study period were followed up at Tokyo Women's Medical University between March 2020 and August 2022. We investigated the outcomes and treatments of infected KTx recipients.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Nineteen (6.7%) patients showed severe outcomes, including eight SARS-CoV-2 infection-related deaths. Risk factors associated with severe outcomes included underlying conditions, such as diabetes mellitus, heart disease, and liver disease (odds ratios, 2.09, 2.88, and 5.52, respectively). Treatment strategies changed throughout the epidemic in response to changes in the SARS-CoV-2 variants. Antiviral drugs were gradually administered as soon as they were approved for use.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Treatment strategies for KTx recipients were gradually established over the course of the epidemic. Although the proportion of infected KTx recipients decreased compared to that of the general population throughout the epidemic, many patients still followed a severe course.</AbstractText><CopyrightInformation>© 2024. The Author(s), under exclusive licence to Japanese Society of Nephrology.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Sekido</LastName><ForeName>Eri</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Unagami</LastName><ForeName>Kohei</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0001-7309-0658</Identifier><AffiliationInfo><Affiliation>Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan. unagami.kohei@twmu.ac.jp.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Organ Transplant Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan. unagami.kohei@twmu.ac.jp.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Omoto</LastName><ForeName>Kazuya</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Tokiwakai Yochomachi Clinic, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arimura</LastName><ForeName>Ken</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Pulmonology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moriyama</LastName><ForeName>Ikumi</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Banno</LastName><ForeName>Taro</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saitoh</LastName><ForeName>Ayaka</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Organ Transplant Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Oki</LastName><ForeName>Rikako</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Organ Transplant Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Okada</LastName><ForeName>Daigo</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yagisawa</LastName><ForeName>Takafumi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kanzawa</LastName><ForeName>Taichi</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kitajima</LastName><ForeName>Kumiko</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Organ Transplant Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hirai</LastName><ForeName>Toshihito</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shimizu</LastName><ForeName>Tomokazu</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Organ Transplant Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yamanaga</LastName><ForeName>Shigeyoshi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Surgery, Japanese Red Cross Kumamoto Hospital, Kumamoto, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Egawa</LastName><ForeName>Hiroto</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Surgery, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Inui</LastName><ForeName>Masashi</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University Yachiyo Medical Center, Chiba, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hoshino</LastName><ForeName>Junichi</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ishida</LastName><ForeName>Hideki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Organ Transplant Medicine, Tokyo Women's Medical University, 8-1 Kawada-cho, Shinjuku-ku, Tokyo, 162-8666, Japan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Takagi</LastName><ForeName>Toshio</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Department of Urology, Tokyo Women's Medical University, Tokyo, Japan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>JPMH20CA2046</GrantID><Agency>MHLW Special Research Program (JP)</Agency><Country /></Grant><Grant><GrantID>JPMH21HA2011</GrantID><Agency>MHLW Research Program on Emerging and Reemerging Infectious Diseases (JP)</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>Japan</Country><MedlineTA>Clin Exp Nephrol</MedlineTA><NlmUniqueID>9709923</NlmUniqueID><ISSNLinking>1342-1751</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Immunosuppressive therapy</Keyword><Keyword MajorTopicYN="N">Kidney transplantation</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>12</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>3</Day><Hour>11</Hour><Minute>16</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39361181</ArticleId><ArticleId IdType="doi">10.1007/s10157-024-02560-0</ArticleId><ArticleId IdType="pii">10.1007/s10157-024-02560-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Ministry of Health, Labour and Welfare of Japan Website [cited March 25, 2024]. Available from: https://covid19.mhlw.go.jp/ .</Citation></Reference><Reference><Citation>Azzi Y, Bartash R, Scalea J, Loarte-Campos P, Akalin E. COVID-19 and solid organ transplantation: a review article. Transplantation. 2021;105(1):37–55. https://doi.org/10.1097/tp.0000000000003523 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/tp.0000000000003523</ArticleId><ArticleId IdType="pubmed">33148977</ArticleId></ArticleIdList></Reference><Reference><Citation>Boyarsky BJ, Werbel WA, Avery RK, Tobian AA, Massie AB, Segev DL, et al. Antibody response to 2-dose SARS-CoV-2 mRNA vaccine series in solid organ transplant recipients. JAMA. 2021;325(21):2204–6. https://doi.org/10.1001/jama.2021.7489 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.7489</ArticleId><ArticleId IdType="pubmed">33950155</ArticleId><ArticleId IdType="pmc">8100911</ArticleId></ArticleIdList></Reference><Reference><Citation>Unagami K, Yoshikawa M, Egawa H, Ohfuji S, Natori Y, Oki R, et al. Delayed peak antibody titers after the second dose of SARS-CoV-2 vaccine in solid organ transplant recipients: prospective cohort study. Vaccine. 2024;42(3):126221.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2024.126221</ArticleId><ArticleId IdType="pubmed">39180977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Luo D, Mei B, Du J, Liu X, Xie H, et al. Immunogenicity of COVID-19 vaccines in solid organ transplant recipients: a systematic review and meta-analysis. Clin Microbiol Infect. 2023;29(4):441–56. https://doi.org/10.1016/j.cmi.2022.12.004 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.12.004</ArticleId><ArticleId IdType="pubmed">36509376</ArticleId></ArticleIdList></Reference><Reference><Citation>Grupper A, Rabinowich L, Schwartz D, Schwartz IF, Ben-Yehoyada M, Shashar M, et al. Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus. Am J Transplant. 2021;21(8):2719–26. https://doi.org/10.1111/ajt.16615 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16615</ArticleId><ArticleId IdType="pubmed">33866672</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal U, Bedston S, McCowan C, Oke J, Patterson L, Robertson C, et al. Severe COVID-19 outcomes after full vaccination of primary schedule and initial boosters: pooled analysis of national prospective cohort studies of 30 million individuals in England, Northern Ireland, Scotland, and Wales. Lancet. 2022;400(10360):1305–20. https://doi.org/10.1016/S0140-6736(22)01656-7 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)01656-7</ArticleId><ArticleId IdType="pubmed">36244382</ArticleId><ArticleId IdType="pmc">9560746</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans RA, Dube S, Lu Y, Yates M, Arnetorp S, Barnes E, et al. Impact of COVID-19 on immunocompromised populations during the Omicron era: insights from the observational population-based INFORM study. Lancet Reg Health Eur. 2023;35: 100747. https://doi.org/10.1016/j.lanepe.2023.100747 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2023.100747</ArticleId><ArticleId IdType="pubmed">38115964</ArticleId><ArticleId IdType="pmc">10730312</ArticleId></ArticleIdList></Reference><Reference><Citation>Jering KS, McGrath MM, Mc Causland FR, Claggett B, Cunningham JW, Solomon SD. Excess mortality in solid organ transplant recipients hospitalized with COVID-19: a large-scale comparison of SOT recipients hospitalized with or without COVID-19. Clin Transplant. 2022;36(1): e14492. https://doi.org/10.1111/ctr.14492 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ctr.14492</ArticleId><ArticleId IdType="pubmed">34558116</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuramitsu K, Yamanaga S, Osawa R, Hibi T, Yoshikawa M, Toyoda M, et al. Impact of COVID-19 on living donor liver and kidney transplantation programs in Japan in 2020. Transpl Infect Dis. 2022;24(3): e13845. https://doi.org/10.1111/tid.13845 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/tid.13845</ArticleId><ArticleId IdType="pubmed">35505462</ArticleId><ArticleId IdType="pmc">9348111</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaga S, Shimata K, Ohfuji S, Yoshikawa M, Natori Y, Hibi T, et al. Excess mortality in COVID-19-affected solid organ transplant recipients across the pandemic. Am J Transplant. 2024;24(8):1495–508. https://doi.org/10.1016/j.ajt.2024.03.016 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajt.2024.03.016</ArticleId><ArticleId IdType="pubmed">38514016</ArticleId></ArticleIdList></Reference><Reference><Citation>The Japan Society for Transplantation website [cited March 25, 2024]. Available from: https://square.umin.ac.jp/jst-covid-19/images/20220831covid-19cases.pdf .</Citation></Reference><Reference><Citation>Coll E, Fernández-Ruiz M, Sánchez-Álvarez JE, Martínez-Fernández JR, Crespo M, Gayoso J, et al. COVID-19 in transplant recipients: the Spanish experience. Am J Transplant. 2021;21(5):1825–37. https://doi.org/10.1111/ajt.16369 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/ajt.16369</ArticleId><ArticleId IdType="pubmed">33098200</ArticleId></ArticleIdList></Reference><Reference><Citation>De Meester J, De Bacquer D, Naesens M, Meijers B, Couttenye MM, De Vriese AS, et al. Incidence, characteristics, and outcome of COVID-19 in adults on kidney replacement therapy: a Regionwide registry study. J Am Soc Nephrol. 2021;32(2):385–96. https://doi.org/10.1681/ASN.2020060875 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1681/ASN.2020060875</ArticleId><ArticleId IdType="pubmed">33154174</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma A, Khorsandi SE, Dolcet A, Prachalias A, Suddle A, Heaton N, et al. Low prevalence and disease severity of COVID-19 in post-liver transplant recipients—a single centre experience. Liver Int. 2020;40(8):1972–6. https://doi.org/10.1111/liv.14552 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/liv.14552</ArticleId><ArticleId IdType="pubmed">32471013</ArticleId><ArticleId IdType="pmc">7300707</ArticleId></ArticleIdList></Reference><Reference><Citation>Nimmo A, Gardiner D, Ushiro-Lumb I, Ravanan R, Forsythe JL. The global impact of COVID-19 on solid organ transplantation: two years into a pandemic. Transplantation. 2022;106(7):1312–29. https://doi.org/10.1097/TP.0000000000004151 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/TP.0000000000004151</ArticleId><ArticleId IdType="pubmed">35404911</ArticleId><ArticleId IdType="pmc">9213067</ArticleId></ArticleIdList></Reference><Reference><Citation>Arimura K, Tagaya E, Kikuchi K, Mitsuda T, Ebihara F, Maruyama T, et al. The efficacy of neutralizing monoclonal antibodies in transplant recipients with mild-to-moderate COVID-19. Transpl Immunol. 2023;77: 101777. https://doi.org/10.1016/j.trim.2022.101777 .</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trim.2022.101777</ArticleId><ArticleId IdType="pubmed">36584927</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>